Redhill Biopharma
RDHL
$0.46
Share price
1.33%
Change (1 day)
-80.25%
Change (1 year)
Categories
Redhill Biopharma (RDHL) - Total assets
Total assets on the balance sheet as of June 2023 : $35.03 M
According to Redhill Biopharma's latest financial reports the company's total assets are $35.03 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Redhill Biopharma - Total assets on balance sheet (from 2011 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.15 B | -12.32% |
| 2021-12-31 | $0.18 B | 0.53% |
| 2020-12-31 | $0.18 B | 143.24% |
| 2019-12-31 | $74.09 M | 18.73% |
| 2018-12-31 | $62.41 M | 8.84% |
| 2017-12-31 | $57.34 M | -22.73% |
| 2016-12-31 | $74.21 M | 11.05% |
| 2015-12-31 | $66.82 M | 131.59% |
| 2014-12-31 | $28.85 M | 101.23% |
| 2013-12-31 | $14.34 M | -28.64% |
| 2012-12-31 | $20.09 M | -0.45% |
| 2011-12-31 | $20.18 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $139.81 B | 398,952.43% | 🇫🇷 France |
 Merck MRK | $105.84 B | 302,006.34% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $73.94 B | 210,939.47% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $42.77 B | 121,979.52% | 🇮🇱 Israel |
 Taro Pharmaceutical TARO | $2.16 B | 6,073.99% | 🇮🇱 Israel |